Why the study?
Severe tricuspid regurgitation carries poor prognosis and limited treatment options, with surgical interventions associated with the highest mortality rates among valve procedures.
Key points are not available for this paper at this time.
Comparison
Transcatheter tricuspid valve replacement vs repair
Design
Pooled analysis
Answers are grounded in this paper and cite their sources.
High mortality restricts surgical options for severe tricuspid regurgitation; leaves open less invasive therapies for end-stage heart failure.
Tricuspid regurgitation is a poor prognostic marker of end-stage heart failure. Treatment options for severe tricuspid regurgitation are currently limited because these procedures have the highest mortality rates of all valve procedures. Isolated tricuspid valve surgery is reserved for rare cases during surgical viability evaluation with repair favored over tricuspid valve replacement, owing to the slightly more favorable mortality and downstream complication associated with the latter.
No takes yet. Share an insight, caveat, or question.
Yaser et al. (2020) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: